Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Retransplantation for recurrent hepatitis C.

Sheiner PA, Schluger LK, Emre S, Thung SN, Lau JY, Guy SR, Schwartz ME, Miller CM.

Liver Transpl Surg. 1997 Mar;3(2):130-6.

2.

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.

Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, Markmann JF, Drazan KE, Holt C, Imagawa D, Goldstein LI, Martin P, Busuttil RW.

Ann Surg. 1999 Jun;229(6):824-31; discussion 831-3.

3.

Graft loss following liver transplantation in patients with chronic hepatitis C.

Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P.

Transplantation. 1996 Dec 27;62(12):1773-6.

PMID:
8990361
4.

To transplant or not to transplant recurrent hepatitis C and liver failure.

Forman LM.

Clin Liver Dis. 2003 Aug;7(3):615-29. Review.

PMID:
14509530
5.

IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.

Negro F, Giostra E, Rubbia-Brandt L, Mentha G, Colucci G, Morel P, Quadri R, Perrin L, Hadengue A.

J Med Virol. 1998 Nov;56(3):224-9.

PMID:
9783689
6.

Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up.

Zein NN, Rakela J, Poterucha JJ, Steers JL, Wiesner RH, Persing DH.

Liver Transpl Surg. 1995 Nov;1(6):354-7.

7.

Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.

Petrovic LM, Villamil FG, Vierling JM, Makowka L, Geller SA.

Liver Transpl Surg. 1997 Jul;3(4):398-406.

8.

Retransplantation for recurrent hepatitis C.

Ghobrial RM.

Liver Transpl. 2002 Oct;8(10 Suppl 1):S38-43. Review.

9.

Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.

Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.

Am J Gastroenterol. 1997 Sep;92(9):1453-7.

PMID:
9317061
10.

Risk factors in liver retransplantation: a single-center experience.

Crivellin C, De Martin E, Germani G, Gambato M, Senzolo M, Russo FP, Vitale A, Zanus G, Cillo U, Burra P.

Transplant Proc. 2011 May;43(4):1110-3. doi: 10.1016/j.transproceed.2011.01.141.

PMID:
21620065
11.

The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.

Teixeira R, Pastacaldi S, Davies S, Dhillon AP, Emery VC, Rolles K, Davidson B, Patch D, Burroughs AK.

Transplantation. 2000 Nov 27;70(10):1454-8.

PMID:
11118089
12.

Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation.

Baiocchi L, Tisone G, Palmieri G, Rapicetta M, Pisani F, Orlando G, Casciani CU, Angelico M.

Liver Transpl Surg. 1998 Nov;4(6):441-7.

13.

Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.

Arnold JC, Töx U, Goeser T, Otto G, Müller HM, Hofmann WJ, Stremmel W, Theilmann L.

Z Gastroenterol. 1997 Apr;35(4):255-61.

PMID:
9163889
14.

Fibrosis/cirrhosis after orthotopic liver transplantation.

Tabatabai L, Lewis WD, Gordon F, Jenkins R, Khettry U.

Hum Pathol. 1999 Jan;30(1):39-47.

PMID:
9923925
15.

Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation.

Schluger LK, Sheiner PA, Thung SN, Lau JY, Min A, Wolf DC, Fiel I, Zhang D, Gerber MA, Miller CM, Bodenheimer HC Jr.

Hepatology. 1996 May;23(5):971-6.

PMID:
8621177
16.

Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.

Crespo J, Carte B, Lozano JL, Casafont F, Rivero M, de la Cruz F, Pons-Romero F.

Am J Gastroenterol. 1997 Sep;92(9):1458-62.

PMID:
9317062
17.

Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.

Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.

Liver Transpl. 2000 Mar;6(2):222-8.

PMID:
10719024
18.

Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.

Bizollon T, Ahmed SN, Guichard S, Chevallier P, Adham M, Ducerf C, Baulieux J, Trepo C.

Gut. 2000 Nov;47(5):698-702.

19.

Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation.

Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Cescon M, Varotti G, Ramacciato G, Vetrone G, Zanello M, Pinna AD.

Liver Transpl. 2006 Jul;12(7):1104-11.

20.

Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome.

Carmiel-Haggai M, Fiel MI, Gaddipati HC, Abittan C, Hossain S, Roayaie S, Schwartz ME, Gondolesi G, Emre S, Schiano TD.

Liver Transpl. 2005 Dec;11(12):1567-73.

Supplemental Content

Support Center